EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Analyst Earnings Estimates
FRA:EWL - Deutsche Boerse Ag - US28176E1082 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.464B -14.69% | 5.01B 12.23% | 5.44B 8.57% | 5.992B 10.16% | 6.575B 9.73% | 7.253B 10.31% | 7.998B 10.27% | 8.748B 9.38% | 9.661B 10.44% | |
| EBITDA YoY % growth | 1.715B -7.11% | 1.657B -3.34% | 1.635B -1.33% | 1.83B 11.91% | 2.081B 13.72% | 2.411B 15.86% | 2.474B 2.61% | 2.767B 11.84% | 3.075B 11.13% | |
| EBIT YoY % growth | 1.575B -7.95% | 1.512B -3.97% | 1.48B -2.14% | 1.653B 11.68% | 1.861B 12.58% | 2.091B 12.36% | 2.33B 11.43% | 2.587B 11.03% | 2.945B 13.84% | |
| Operating Margin | 35.28% | 30.19% | 27.21% | 27.59% | 28.30% | 28.83% | 29.13% | 29.57% | 30.48% | |
| EPS YoY % growth | 2.48 11.21% | 2.51 1.21% | 2.62 4.38% | 2.53 -3.61% | 2.83 12.03% | 3.18 12.33% | 3.59 13.08% | 4.18 16.26% | 4.61 10.45% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.62 -6.64% | 0.64 -9.16% | 0.63 -6.37% | 0.65 9.77% | 0.66 6.65% | 0.70 9.83% | 0.70 11.65% | 0.74 14.35% | 0.74 12.85% | 0.79 13.57% | 0.82 17.65% | 0.84 14.05% |
| Revenue Q2Q % growth | 1.444B -9.65% | 1.503B -7.92% | 1.492B 10.16% | 1.546B 11.56% | 1.568B 8.59% | 1.635B 8.78% | 1.628B 9.12% | 1.703B 10.16% | 1.713B 9.25% | 1.816B 11.07% | 1.857B 14.07% | 1.916B 12.51% |
| EBITDA Q2Q % growth | 436.35M 9.50% | 451.33M -0.87% | 447.43M -11.73% | 465.35M -8.49% | 471.48M 8.05% | 508.06M 12.57% | 506.17M 13.13% | 537.09M 15.42% | 536.33M 13.75% | 571.1M 12.41% | 586.16M 15.80% | 608.95M 13.38% |
| EBIT Q2Q % growth | 394.46M 9.57% | 412.15M 9.27% | 409.36M 3.82% | 426.76M 20.79% | 422.31M 7.06% | 458.39M 11.22% | 456.62M 11.54% | 489.07M 14.60% | 489.9M 16.00% | 524.14M 14.34% | 537.7M 17.76% | 559.96M 14.49% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.59 -7.81% | 0.57 | 0.02 | 3.40% |
| Q3 2024 Q2Q % growth | 0.67 13.56% | 0.66 | 0.01 | 1.57% |
| Q2 2024 Q2Q % growth | 0.70 6.06% | 0.71 | -0.01 | -2.08% |
| Q1 2024 Q2Q % growth | 0.66 6.45% | 0.66 | 0.00 | -0.31% |
| Q4 2023 Q2Q % growth | 0.64 | 0.66 | -0.02 | -2.52% |
| Q3 2023 Q2Q % growth | 0.59 -3.28% | 0.61 | -0.02 | -3.30% |
| Q2 2023 Q2Q % growth | 0.66 4.76% | 0.67 | -0.01 | -0.94% |
| Q1 2023 Q2Q % growth | 0.62 3.33% | 0.63 | -0.01 | -0.87% |
| Q4 2022 Q2Q % growth | 0.64 25.49% | 0.63 | 0.01 | 1.49% |
| Q3 2022 Q2Q % growth | 0.61 12.96% | 0.64 | -0.03 | -4.88% |
| Q2 2022 Q2Q % growth | 0.63 -1.56% | 0.66 | -0.03 | -4.56% |
| Q1 2022 Q2Q % growth | 0.60 11.11% | 0.59 | 0.01 | 1.57% |
| Q4 2021 Q2Q % growth | 0.51 2.00% | 0.56 | -0.05 | -9.65% |
| Q3 2021 Q2Q % growth | 0.54 5.88% | 0.55 | -0.01 | -1.80% |
| Q2 2021 Q2Q % growth | 0.64 88.24% | 0.57 | 0.07 | 11.77% |
| Q1 2021 Q2Q % growth | 0.54 7.29% | 0.49 | 0.05 | 10.58% |
| Q4 2020 Q2Q % growth | 0.50 2.74% | 0.55 | -0.05 | -8.69% |
| Q3 2020 Q2Q % growth | 0.51 8.51% | 0.46 | 0.05 | 11.83% |
| Q2 2020 Q2Q % growth | 0.34 -26.09% | 0.18 | 0.16 | 93.54% |
| Q1 2020 Q2Q % growth | 0.50 14.39% | 0.46 | 0.04 | 9.49% |
| Q4 2019 Q2Q % growth | 0.49 | 0.51 | -0.02 | -4.58% |
| Q3 2019 Q2Q % growth | 0.47 | 0.42 | 0.05 | 12.29% |
| Q2 2019 Q2Q % growth | 0.46 | 0.46 | 0.00 | 0.80% |
| Q1 2019 Q2Q % growth | 0.44 | 0.42 | 0.02 | 4.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.386B -9.67% | 1.398B | -12.2M | -0.87% |
| Q3 2024 Q2Q % growth | 1.354B -8.54% | 1.571B | -216.6M | -13.79% |
| Q2 2024 Q2Q % growth | 1.632B 6.67% | 1.702B | -69.7M | -4.10% |
| Q1 2024 Q2Q % growth | 1.598B 9.50% | 1.616B | -17.8M | -1.10% |
| Q4 2023 Q2Q % growth | 1.534B 13.78% | 1.54B | -5.9M | -0.38% |
| Q3 2023 Q2Q % growth | 1.481B 12.27% | 1.523B | -42.1M | -2.76% |
| Q2 2023 Q2Q % growth | 1.53B 11.38% | 1.549B | -18.8M | -1.21% |
| Q1 2023 Q2Q % growth | 1.46B 8.83% | 1.435B | 24.6M | 1.71% |
| Q4 2022 Q2Q % growth | 1.348B 1.40% | 1.369B | -20.7M | -1.51% |
| Q3 2022 Q2Q % growth | 1.319B 0.67% | 1.373B | -54M | -3.93% |
| Q2 2022 Q2Q % growth | 1.374B -0.15% | 1.443B | -69.1M | -4.79% |
| Q1 2022 Q2Q % growth | 1.341B 10.24% | 1.353B | -11.8M | -0.87% |
| Q4 2021 Q2Q % growth | 1.33B 11.58% | 1.395B | -65.3M | -4.68% |
| Q3 2021 Q2Q % growth | 1.31B 14.84% | 1.361B | -50.8M | -3.73% |
| Q2 2021 Q2Q % growth | 1.376B 48.76% | 1.317B | 59M | 4.48% |
| Q1 2021 Q2Q % growth | 1.217B 7.79% | 1.199B | 17.6M | 1.47% |
| Q4 2020 Q2Q % growth | 1.192B 1.50% | 1.224B | -32.3M | -2.64% |
| Q3 2020 Q2Q % growth | 1.141B 4.29% | 1.113B | 27.9M | 2.51% |
| Q2 2020 Q2Q % growth | 925M -14.90% | 821.45M | 103.55M | 12.61% |
| Q1 2020 Q2Q % growth | 1.129B 13.67% | 1.116B | 12.7M | 1.14% |
| Q4 2019 Q2Q % growth | 1.174B | 1.178B | -3.9M | -0.33% |
| Q3 2019 Q2Q % growth | 1.094B | 1.069B | 25M | 2.34% |
| Q2 2019 Q2Q % growth | 1.087B | 1.076B | 10.9M | 1.01% |
| Q1 2019 Q2Q % growth | 993M | 1.02B | -27M | -2.65% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.91% | 2.29% | 0.35% | 0.69% |
| Revenue | -0.76% | -2.1% | -0.17% | -1.53% |